These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32918829)

  • 21. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
    Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
    Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine and Hydroxychloroquine in COVID-19: Challenges and the Need for Caution in Low-Resource Settings.
    Islam M
    J Coll Physicians Surg Pak; 2020 Jun; 30(6):78. PubMed ID: 32723461
    [No Abstract]   [Full Text] [Related]  

  • 23. Ventricular arrhythmia risk due to chloroquine / hydroxychloroquine treatment for COVID-19: Should it be given.
    Malviya A
    Indian Heart J; 2020; 72(2):131-132. PubMed ID: 32534688
    [No Abstract]   [Full Text] [Related]  

  • 24. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
    Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
    Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae.
    Hamm BS; Rosenthal LJ
    Psychosomatics; 2020; 61(6):597-606. PubMed ID: 32800347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous.
    White CM; Hernandez AV
    J Clin Pharmacol; 2020 Aug; 60(8):949-953. PubMed ID: 32530493
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
    Oren O; Yang EH; Gluckman TJ; Michos ED; Blumenthal RS; Gersh BJ
    Circ Arrhythm Electrophysiol; 2020 Jun; 13(6):e008688. PubMed ID: 32436730
    [No Abstract]   [Full Text] [Related]  

  • 28. Ventricular repolarization indexes in patients treated with hydroxychloroquine - azithromycin combination for COVID-19.
    Gunay S; Caliskan S; Sigirli D; Sahin E
    Bratisl Lek Listy; 2020; 121(11):817-821. PubMed ID: 33164544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS-CoV-2 Lower Respiratory Tract Infection.
    Bun SS; Taghji P; Courjon J; Squara F; Scarlatti D; Theodore G; Baudouy D; Sartre B; Labbaoui M; Dellamonica J; Doyen D; Marquette CH; Levraut J; Esnault V; Bun SS; Ferrari E
    Clin Pharmacol Ther; 2020 Nov; 108(5):1090-1097. PubMed ID: 32588427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
    Roustit M; Guilhaumou R; Molimard M; Drici MD; Laporte S; Montastruc JL;
    Therapie; 2020; 75(4):363-370. PubMed ID: 32473812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hydroxychloroquine treatment on QT interval.
    Hooks M; Bart B; Vardeny O; Westanmo A; Adabag S
    Heart Rhythm; 2020 Nov; 17(11):1930-1935. PubMed ID: 32610165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    White NJ; Watson JA; Hoglund RM; Chan XHS; Cheah PY; Tarning J
    PLoS Med; 2020 Sep; 17(9):e1003252. PubMed ID: 32881895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QT interval evaluation associated with the use of hydroxychloroquine with combined use of azithromycin among hospitalised children positive for coronavirus disease 2019.
    Tuncer T; Karaci M; Boga A; Durmaz H; Guven S
    Cardiol Young; 2020 Oct; 30(10):1482-1485. PubMed ID: 32686633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 35. Chloroquine and hydroxychloroquine in covid-19.
    Ferner RE; Aronson JK
    BMJ; 2020 Apr; 369():m1432. PubMed ID: 32269046
    [No Abstract]   [Full Text] [Related]  

  • 36. Suspected Hydroxychloroquine-Induced Sinus Bradycardia and QTc Prolongation in a Patient with COVID-19.
    Kang Y; Wang H; Chen H; Wang B; Yang Y; Zhao X; Ran Q; Wei J
    Int Heart J; 2020 Sep; 61(5):1056-1058. PubMed ID: 32921678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulators split on antimalarials for COVID-19.
    Jaffe S
    Lancet; 2020 Apr; 395(10231):1179. PubMed ID: 32278373
    [No Abstract]   [Full Text] [Related]  

  • 38. Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.
    Mahalmani VM; Mahendru D; Sarma P; Prakash A; Medhi B
    Indian J Pharmacol; 2020; 52(2):75-78. PubMed ID: 32565593
    [No Abstract]   [Full Text] [Related]  

  • 39. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
    Piszczatoski CR; Powell J
    Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.